摘要
临床结局指标是评估治疗效果和医疗服务质量的关键指标。传统的临床结局指标忽视了患者的主观感受,因此近年来患者报告结局(PRO)备受关注。在肿瘤领域,PRO可用于评估和监测症状,调查治疗满意度等,并对治疗决策和医疗政策产生影响。目前基于PRO的线上系统越来越受到重视。在肿瘤营养领域,电子患者报告结局(ePRO)系统可被应用于营养筛查、监测和管理,以此来提高干预效率,减轻医护人员负担,并促进患者对营养干预的积极性。随着人工智能的兴起,未来基于PRO的临床支持系统更有望改变传统的决策模式,进一步优化医疗服务质量。因此,本共识依据专家意见,以及国内外最新研究进展和应用实践,提出了ePRO系统在肿瘤营养临床和科研环境中的规范应用建议,以期推动肿瘤营养诊疗的高效性和全程性。
Clinical outcome measures are essential to evaluate the effects of treatment and the quality of healthcare service.Traditional measures often overlook patients'subjective experiences,leading to a growing focus on patient-repoted outomes(PRO)in recent years.In the field of oncology,PRO may cover symptom assessmnent and monitoring,satisfaction with care,and inform treatment decisions and health policy.The increasing recognition of the electronic patient-reported outcome(ePRO)system in nutritional oncology highlights its potential for enbancing the fficiency of mutional intervention,reducing the burden on healtheare professionals,and encouraging patient engagement in nutrition interventions.With the rise of artificial itelligence,future clinical support systems based on PRO hold the promise of transforming traditional decision-making models,further optimizing healthcare service quality.Therefore,based on expert opinions and existing evidence,this consensus offers recommendations for the standardized application of ePRO systems in clinical practice and research,aiming to promote eficiency and couprehensiveness of nutitional management in oncology settings.
出处
《肿瘤代谢与营养电子杂志》
2024年第2期169-180,共12页
Electronic Journal of Metabolism and Nutrition of Cancer
基金
吴阶平医学基金会临床科研专项资助基金(320.6750.2021-02-22)。
关键词
患者报告结局
电子患者报告结局系统
患者报告结局测量工具
肿瘤营养
人工智能
Patient-reported outome
Electronic patient-reported outcome system
Patient-reported outcome measurement
Nutritional oncology
Artificial itelligence
